维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

12篇 您的检索式：作者名="Labarthe M C"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Inhibition and reversal of platelet aggregation by alphalIbbeta3 antagonists depends on the anticoagulant and flow conditions:differential effects of Abciximab and l_amifiban显示文摘	Frojmovie M Labarthe B Legrand C	2005	Br J Haematol2005，131，3：	1
	2	Theanti-cancer agents lenalidomide and pomalidomide inhibitthe proliferation and function of T regulatory cells 显示文摘	GALUSTIAN C MEYER B LABARTHE M C	2009	Cancer Immunol Immunother2009，58，7：	1
	3	Immunotherapeutic potential of whole tumour cells 显示文摘	Ward S Casey D Labarthe M C	2002	Cancer Immunol Immunother2002，51，7：	1
	4	Inhibition and reversal of platelet aggregation by alphaIIbbeta3 antagonists depends on the anticoagulant and flow conditions: differential effects of Abciximab and Lamifiban 显示文摘	Frojmovic M Labarthe B Legrand C	2005	Br J Haematol2005，131，3：	1
	5	Inhibition and reversal of platelet aggregation by alphaIIbbeta3 antagonists depends on the anticoagulant and flow conditions:differential effects of Abciximab and Lamifiban显示文摘	Frojmovic M Labarthe B Legrand C	2005	Br J Haematol2005，131，3：	1
	6	Inhibition and reversal of platelet aggregation by alphaIIbbeta3 antagonists depends on the anticoagulant and flow conditions: differential effects of Abciximab and Lamiflban 显示文摘	Frojmovic M Labarthe B Legrand C	2005	Br J Haematol2005，131，3：	1
	7	Inhibition and reversal of platelet aggregation by alphaIIbbeta3 antagonists de- pends on the anticoagulant and flow conditions: differential, ef- fects of Abciximab and Lamifibam 显示文摘	FROJMOVIC M LABARTHE B LEGRAND C	2009	Br J Haematol2009，131，3：	1
	8	The anticancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells 显示文摘	Galustian C Meyer B Labarthe M	2009	Cancer Immunology Immunotherapy2009，58，7：	1
	9	Inhibition and reversal of platelet aggregation by alphallbbeta3 antagonists depends on the anticoagulant and flow conditions : differential effects of Abci~imab and Lamifiban 显示文摘	Frojmovic M Labarthe B Legrand C	2005	Br J Haematol2005，131，：	1
	10	The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function ofT regulatory cells 显示文摘	Galustian C Meyer B Labarthe M	2009	Cancer Immunology Immunotherapy2009，58，7：	1
	11	Inhibition and reversal of platelet aggregation by alphaIIbbeta3 antagonists depends on the anticoagulant and flow conditions:differential effects of Abciximab and Lamifiban显示文摘	Frojmovic M Labarthe B Legrand C	2005	Br J Haematol2005，131，3：	1
	12	Thalidomide - derived immunomodulatory drugs as thera- peutic agents显示文摘	GALUSTIAN C LABARTHE M C BARTLETT J B	2004	Expert Opin Biol Ther2004，4，12：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费